- Corporate Officers - H
- Helsel Dave
Insider Trading History of Helsel Dave
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Helsel Dave since 2012.
This trader's CIK number is 1543753.
At the time of last reporting, Helsel Dave was the SVP Global Operations and R&D of Angiodynamics Inc. (stock ticker symbol ANGO).
Also see all insider trading activities at Angiodynamics Inc.
Note that in the past
Helsel Dave also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Haemonetics Corp (HAE) by Helsel Dave
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | HAE | 272 | $8,901 | 0 | $0 | 0 | $0 |
| 2012 | HAE | 144 | $8,849 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Angiodynamics Inc (ANGO) by Helsel Dave
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ANGO | 0 | $0 | 4,633 | $59,997 | 4,371 | $0 |
| 2022 | ANGO | 0 | $0 | 8,513 | $191,031 | 3,480 | $0 |
| 2021 | ANGO | 0 | $0 | 6,994 | $181,482 | 2,685 | $0 |
Insider trading activities at 2 companies by Helsel Dave:
1. Haemonetics Corp (HAE)
2. Angiodynamics Inc (ANGO)
Table 1. Insider trading of Haemonetics Corp (HAE) by Helsel Dave
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-04-30 | HAE | Buy | 272 | 32.73 | 8,901 |
| 2012-11-01 | HAE | Buy | 144 | 61.45 | 8,849 |
Table 2. Insider trading of Angiodynamics Inc (ANGO) by Helsel Dave
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-19 | ANGO | Option Ex | 4,371 | .00 | 0 |
| 2023-01-31 | ANGO | Sale | 4,633 | 12.95 | 59,997 |
| 2022-07-29 | ANGO | Sale | 5,000 | 22.44 | 112,200 |
| 2022-07-07 | ANGO | Option Ex | 3,480 | .00 | 0 |
| 2022-04-28 | ANGO | Sale | 3,513 | 22.44 | 78,831 |
| 2021-10-20 | ANGO | Sale | 3,494 | 27.97 | 97,727 |
| 2021-08-12 | ANGO | Option Ex | 2,685 | .00 | 0 |
| 2021-04-14 | ANGO | Sale | 3,500 | 23.93 | 83,755 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Helsel Dave
(SVP Global Operations and R&D of Angiodynamics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.